78 related articles for article (PubMed ID: 3673344)
1. Uptake of selected antibacterial agents in Mycobacterium avium.
David HL; Clavel-Seres S; Clement F; Goh KS
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):385-92. PubMed ID: 3673344
[TBL] [Abstract][Full Text] [Related]
2. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
Sula L; Sulová J
Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
[No Abstract] [Full Text] [Related]
3. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains.
Tsukamura M; Miyachi T
Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064
[TBL] [Abstract][Full Text] [Related]
4. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
5. [Determination of the minimal inhibitory concentration of chemotherapeutic drugs with various methods against Mycobacterium avium].
Rüsch-Gerdes S
Pneumologie; 1993 Aug; 47(8):497-500. PubMed ID: 8378297
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
7. [A susceptibility study of Mycobacterium avium-intracellulare strains using the broth macrodilution method].
Mederos Cuervo LM; Ferrá Salazar C; Jimenez Misas CA; Valdivia Alvarez JA
Rev Cubana Med Trop; 1995; 47(1):54-8. PubMed ID: 9805069
[TBL] [Abstract][Full Text] [Related]
8. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
[TBL] [Abstract][Full Text] [Related]
9. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Bhusal Y; Shiohira CM; Yamane N
Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
[TBL] [Abstract][Full Text] [Related]
10. [Interrelationship among colonial morphology, susceptibility to antituberculosis drugs, growth rate, and viability in Dubos liquid medium in Mycobacterium avium complex strains].
Tsukamura M
Kekkaku; 1989 Dec; 64(12):753-9. PubMed ID: 2615130
[TBL] [Abstract][Full Text] [Related]
11. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
Tomioka H; Saito H
Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
[TBL] [Abstract][Full Text] [Related]
12. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
13. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
14. Effects of isoniazid on viability, cell morphologies and acid fastness properties of Mycobacterium avium NCTC 8559 during the growth cycle.
Mohamad S; Ibrahim P; Wahab HA
Chemotherapy; 2007; 53(4):263-6. PubMed ID: 17595540
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
Sato K; Tomioka H
Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
[TBL] [Abstract][Full Text] [Related]
16. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
17. [Extra and intracellular activity of dirithromycin against Mycobacterium avium].
Gevaudan MJ; De Micco P
Pathol Biol (Paris); 1995 Apr; 43(4):284-8. PubMed ID: 7567116
[TBL] [Abstract][Full Text] [Related]
18. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
Yamamoto S; Toida I; Watanabe N; Ura T
Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
[TBL] [Abstract][Full Text] [Related]
19. The relative drug susceptibility of opaque colonial forms of Mycobacterium intracellulare-avium: does it affect therapeutic results?
Moulding T
Am Rev Respir Dis; 1978 Jun; 117(6):1142-3. PubMed ID: 666109
[No Abstract] [Full Text] [Related]
20. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.
Vanitha JD; Paramasivan CN
Diagn Microbiol Infect Dis; 2004 Jul; 49(3):179-82. PubMed ID: 15246507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
